Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon- γ production

Blood

Volumn 93, Issue 11, 1999, Pages 3876-3884

  Cifone, M Grazia ^a   D'Alò, Simona ^a   Parroni, Raffaella ^a   Millimaggi, Danilo ^a   Biordi, Leda ^a   Martinotti, Stefano ^a   Santoni, Angela ^a  

^a Department of Experimental Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXICITY; ENZYME INDUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TARGET CELL;

EID: 0033153104     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.11.3876.411k25_3876_3884     Document Type: Article

References (53)

1. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
2. Krahenbuhl O, Rey C, Renne D, Lanzavecchia A, Groscurth P, Carrel S, Tschopp J: Characterization of granzymes A and B isolated from granules of cloned hyman cytotoxic T lymphocytes. J Immunol 141:2471, 1988
3. Shi L, Kraut RP, Aebersold R, Greenberg AH.: A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175:553, 1992
4. Arase H, Arase N, Saito T: Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235, 1995
5. Eischen CM, Schilling JD, Lynch DH, Krammer PH, Leibson PJ: Fc Receptor-induced expression of Fas Ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 156:2693, 1996
6. Henney CS, Kuribayashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature 291:335, 1981
7. Konjevich G, Schlesinger B, Cheng L, Olsen KJ, Podack ER, Spuzic I: Analysis of perform expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2. Immunol Invest 24:499, 1995
8. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B: Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160:1147, 1984
9. Melder RJ, Walker E, Herberman RB, Whiteside TL: Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell Immunol 132:177, 1991
10. Cifone MG, Festuccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A: Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell Immunol 157:181, 1994
11. Juretic A, Spagnoli GC, Von Bremen K, Horig H, Figueira L, Luscher U, Babst R, Harder F, Heberer M: Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent. Cell Immunol 157:462, 1994
12. Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB Jr, Samlowski WE: Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. J Immunol 155:4382, 1995
13. Xiao L, Eneroth PH, Qureshi GA: Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand J Immunol 42:505, 1995
14. Orucevuic A, Lala PK: Effects of N(G)-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell Immunol 169:125, 1996
15. Chambers WH, Vujanovic NL, DeLeo AB, Olszowsky MW, Herberman RB, Hiserodt JC: Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 169:1373, 1989
16. Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M: NKR-P1, a signal transduction molecule on natural killer cells. Science 249:1298, 1990
17. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, Macmicking J, Rollinghoff M, Gresser I, Bogdan C: Type 1 interferon and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77, 1998
18. Nathan C: Inducible nitric oxide synthase: What differences does it make? J Clin Invest 100:2417, 1997
19. Mayer B, Hemmens B: Biosynthesis and action of nitric oxide in mammalian cells. TIBS 22:477, 1997
20. Moncada S, Higgs EA: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002, 1993
21. Michel T, Feron O: Nitric oxide synthases: Which, where, how, and why? J Clin Invest 100:2146, 1997
22. Moncada S, Palmer RMJ, Higgs EA: Biosynthesis of nitric oxide from L-arginine: A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709, 1989
23. MacMicking J, Xie Q, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323, 1997
24. Brune B, Mohr S, Messmer UK: Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev Physiol Biochem Pharmacol 127:1, 1995
25. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS, Keefer LK: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001, 1991
26. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89:3030, 1992
27. Macmicking JD, Nathan C, Hom G, Chatrain N, Fletcher DS, Trambauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641, 1995
28. Wie X-Q, Charles IG, Smith A, Ure J, Feng G-J, Huang F-P, Xu D, Muller W, Moncada S, Liew FY: Altered immune response in mice lacking inducible nitric oxide synthase. Nature 375:408, 1995
29. Cifone MG, Roncaioli P, Cironi L, Festuccia C, Meccia A, D'Alò S, Botti D, Santoni A: NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity. J Immunol 159:309, 1997
30. Vujanovic NK, Herberman RB, Hiserodt JC: Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 167:15, 1988
31. 15N]nitrate in biological fluids. Anal Biochem 126:131, 1982
32. Bredt DS, Schmidt HHHW: The citrulline assay, in Feelisch M, Stamler S (eds): Methods in Nitric Oxide Research. New York, NY, Wiley, 1996, p 249
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
34. 2+ handling. J Biol Chem 270:29304, 1996
35. Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 10:2377, 1996
36. Matzinger P: The JAM test. A simple method for DNA fragmentation and cell death. J Immunol Methods 145:185, 1991
37. Trinchieri G: Natural killer cells wear different hats: Effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin Immunol 7:83, 1995
38. Scott P, Trinchieri G: The role of natural killer cells in host-parasite interaction. Curr Opin Immunol 7:34, 1995
39. Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9:24, 1997
40. Salvucci O, Kolb JP, Dugas B, Dugas N, Choualb S: The induction of nitric oxide by interleukin-12 and tumor necrosis factor-α in human natural killer cells: Relationship with regulation of lytic activity. Blood 92:2093, 1998
41. Cifone MG, Cironi L, Meccia MA, Roncaioli P, Festuccia C, De Nuntiis G, D'Alò S, Santoni A: Role of nitric oxide in cell-mediated cytotoxicity. Adv Neuroimmunol 5:443, 1995
42. Filep JG, Baron C, Lachance S, Perreault C, Chan JS: Involvement of nitric oxide in target-cell lysis and DNA fragmentation induced by murine natural killer cells. Blood 87:5136, 1996
43. Lander HM: An essential role for free radicals and derived species in signal transduction. FASEB J 11:118, 1997
44. Duhé RJ, Evans GA, Erwin RA, Kirken RA, Cox GW, Farrar WL: Nitric oxide and thiol redox regulation of Janus kinase activity. Proc Natl Acad Sci USA 95:126, 1998
45. Bogdan C: The multiplex function of nitric oxide in (Auto)immunity. J Exp Med 187:1361, 1998
46. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, Tweardy DJ: Essential role for induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187:917, 1998
47. Fang FC: Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99:2818, 1997
48. Palmieri G, Serra A, De Maria R, Gismondi A, Milella M, Piccoli M, Frati L, Santoni A: Cross-linking of α4β1 and α5β1 fibronectin receptors enhances natural killer cytotoxic activity. J Immunol 135: 5314, 1995
49. Mainiero F, Gismondi A, Soriani A, Cippitelli M, Palmieri G, Jacobelli J, Piccoli M, Frati L, Santoni A: Integrin-mediated Ras-extracellular regulated kinase (ERK) signaling regulates interferon γ production in human natural killer cells. J Exp Med 188:1267, 1998
50. Tay CH, Welsh RM: Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 71:267, 1997
51. Murphy WJ, Longo DL: NK cells in the regulation of hematopoiesis. Methods 9:344, 1996
52. Maciejewski JP, Sellen C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS: Nitric oxide suppression on human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 96:1085, 1995
53. Lee JW, Beckham C, Michel BR, Rosen H, Deeg HJ: HLA-DR-mediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway. Blood 90:217, 1997